Advertisement
Advertisement
U.S. markets open in 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Premier Biomedical, Inc. (BIEI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0028+0.0001 (+2.22%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0027
Open0.0029
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0026 - 0.0029
52 Week Range0.0012 - 0.0072
Volume17,337,665
Avg. Volume6,539,155
Market Cap2.76M
Beta (5Y Monthly)-4.93
PE Ratio (TTM)N/A
EPS (TTM)-0.0070
Earnings DateNov 02, 2020 - Nov 03, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BIEI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • PREMIER BIOMEDICAL INC
    NKTR: What does Argus have to say about NKTR?NEKTAR THERAPEUTICS has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • We're sorry we weren't able to find anything about this topic.

Advertisement
Advertisement